Food allergies and intolerances in patients with fibromyalgia: the state of the art
Beyond Rheumatology 2024;
6
(1)
: e509
DOI: 10.53238/br_20244_509
Topic: Fibromyalgia and related syndromes, Nutrition
Category: Review
Abstract
The approach to adverse reactions to food represents a difficult task for clinicians due to several unmet needs encompassing all the phases of the medical act. Globally, the prevalence of these reactions shows a progressive increase, but it should be considered that the prevalence of food allergy is largely affected by the diagnostic test used; nonetheless, the lack of accurate tests makes it difficult to calculate the prevalence of food intolerance. In patients suffering from fibromyalgia, food intake is very frequently reported as one of the main responsible for worsening of symptoms, and at diagnosis many patients have already modified their diet, often without a previous nutritional evaluation. Patients frequently start a gluten-free diet and/or a lactose-free diet before the real need is ascertained. Dairy products, incompletely absorbed carbohydrates and gluten-containing foods represent the products the patients consider more frequently the culprit of the onset or worsening of their symptoms. However, the known nocebo effect of foods may induce patients to erroneously associate some foods to symptom onset, also causing a useless elimination diet. The strict association between fibromyalgia and functional gastrointestinal disorders increases the difficulty clinicians have to front during diagnostic approach. Further studies are needed to define the real prevalence of allergy and intolerance in fibromyalgia and to select foods with a negative or positive effect on symptoms.
To cite this article
Food allergies and intolerances in patients with fibromyalgia: the state of the art
Beyond Rheumatology 2024;
6
(1)
: e509
DOI: 10.53238/br_20244_509
Publication History
Submission date: 15 Oct 2023
Revised on: 02 Jan 2024
Accepted on: 13 Mar 2024
Published online: 02 Apr 2024
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.